Literature DB >> 33791141

Penile Glans Necrosis following Prostatic Artery Embolization for the Treatment of Benign Prostatic Hyperplasia: A Rare but Serious Complication.

Eric Chung1,2,3.   

Abstract

BACKGROUND: Prostate artery embolization (PAE) is a novel endovascular procedure to treat men with benign prostatic hyperplasia (BPH) symptoms who wish to maintain sexual potency postoperatively. However, serious treatment-related adverse events (TRAEs) of PAE such as penile glans necrosis (PGN) can be devastating and require urgent attention. Case presentation. Mr GM is a 65-year-old sexually active Anglo-Saxon man who have long-standing BPH symptoms unresponsive to medical therapy. While he had an uneventful bilateral superselective PAE using gel foam, there were signs to suggest of PGN, and this was treated conservatively. The patient presented to the emergency department 5 days later with a painful, dark penile glans and accompanying urinary dysuria and hematuria. Clinical examination confirmed evolving PGN. He received 10 courses of hyperbaric oxygen therapy (HBOT) with complete resolution of his PGN.
CONCLUSION: While superselective embolization is usually always performed, nontarget embolization may occur, as intravascular particles may reflux into adjacent vessels. In this unique and extremely rare case report of PGN following PAE, complete resolution was achieved with HBOT. Proposed benefits of HBOT include anti-inflammation, promotion of neovascularization, and induced rate of collagen deposition, resulting in a faster and more effective resolution of PGN.
Copyright © 2021 Eric Chung.

Entities:  

Year:  2021        PMID: 33791141      PMCID: PMC7984866          DOI: 10.1155/2021/6662899

Source DB:  PubMed          Journal:  Case Rep Urol


  7 in total

Review 1.  A Review of Adverse Events Related to Prostatic Artery Embolization for Treatment of Bladder Outlet Obstruction Due to BPH.

Authors:  Airton Mota Moreira; André Moreira de Assis; Francisco Cesar Carnevale; Alberto Azoubel Antunes; Miguel Srougi; Giovanni Guido Cerri
Journal:  Cardiovasc Intervent Radiol       Date:  2017-08-09       Impact factor: 2.740

2.  Prostatic Arterial Embolization Treating Moderate-to-Severe Lower Urinary Tract Symptoms Related to Benign Prostate Hyperplasia: A Meta-Analysis.

Authors:  Shijian Feng; Ye Tian; Wei Liu; Zirui Li; Tuo Deng; Hong Li; Kunjie Wang
Journal:  Cardiovasc Intervent Radiol       Date:  2016-11-21       Impact factor: 2.740

3.  Ischemia of the Glans Penis following Prostatic Artery Embolization.

Authors:  Nestor Kisilevzky; Cyro Laudanna Neto; Arnaldo Cividanes
Journal:  J Vasc Interv Radiol       Date:  2016-11       Impact factor: 3.464

Review 4.  The role of prostatic arterial embolization in patients with benign prostatic hyperplasia: a systematic review.

Authors:  S M Schreuder; A E Scholtens; J A Reekers; S Bipat
Journal:  Cardiovasc Intervent Radiol       Date:  2014-07-09       Impact factor: 2.740

5.  Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: 10 Years' Experience.

Authors:  Francisco Cesar Carnevale; Airton Mota Moreira; Andre Moreira de Assis; Alberto Azoubel Antunes; Vanessa Cristina de Paula Rodrigues; Miguel Srougi; Giovanni Guido Cerri
Journal:  Radiology       Date:  2020-06-02       Impact factor: 11.105

Review 6.  Prostatic Artery Embolization (PAE) for Symptomatic Benign Prostatic Hyperplasia (BPH): Part 2, Insights into the Technical Rationale.

Authors:  Fei Sun; Verónica Crisóstomo; Claudia Báez-Díaz; Francisco M Sánchez
Journal:  Cardiovasc Intervent Radiol       Date:  2015-11-12       Impact factor: 2.740

Review 7.  Clinical utility of hyperbaric oxygen therapy in genitourinary medicine.

Authors:  Jason Gandhi; Omar Seyam; Noel L Smith; Gunjan Joshi; Sohrab Vatsia; Sardar Ali Khan
Journal:  Med Gas Res       Date:  2018-04-18
  7 in total
  1 in total

1.  Use of hyperbaric oxygen therapy to treat glans penis necrosis after prostatic artery embolization.

Authors:  Kelly Johnson-Arbor; David Field
Journal:  Urol Case Rep       Date:  2022-09-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.